Skip to main navigation Skip to search Skip to main content

Relapse-free survival in gastric cancer patients after upfront surgery vs. neoadjuvant chemotherapy

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish
PagesLB-1518
Publication statusPublished - 2022
EventInternational Gastric Cancer Congress (IGCC) 2022 - online, Houston, United States
Duration: 6 Mar 20229 Mar 2022
https://gastriccancerconference.com/

Congress

CongressInternational Gastric Cancer Congress (IGCC) 2022
Abbreviated titleIGCC 2022
Country/TerritoryUnited States
CityHouston
Period6/03/229/03/22
Internet address

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords*

  • Gastric cancer
  • Neoadjuvant chemotherapy
  • nomogram

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.4. Other publications in conference proceedings (including local)

Cite this